Biogen (BIIB) Tops Q3 EPS by 60c, Beats on Revenue; Offers FY26 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $248.93 -0.03%
Financial Fact:
Diluted earnings per share attributable to Biogen Idec Inc.: 4.71
Today's EPS Names:
FUSE, INM, TRI, More
Financial Fact:
Diluted earnings per share attributable to Biogen Idec Inc.: 4.71
Today's EPS Names:
FUSE, INM, TRI, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q3 EPS of $2.62, $0.60 better than the analyst estimate of $2.02. Revenue for the quarter came in at $2.8 billion versus the consensus estimate of $2.64 billion.
GUIDANCE:
Biogen sees FY2026 EPS of $12.20-$13.00, versus the consensus of $12.36.
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- Spyre Therapeutics, Inc. (SYRE) Misses Q3 EPS by 16c
- Essential Utilities, Inc. (WTRG) Tops Q3 EPS by 4c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
